Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: June 19, 2013

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Invokana	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pertzye	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vascepa	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Myrbetriq	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tecfidera	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Nesina	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Diclegis	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tradjenta	New Drug Appeal	Require Prior Approval	Prior Approval Required
Tudorza Pressair	New Drug Appeal	Require Prior Approval	Prior Approval Required
Stribild	New Drug Appeal	Require Prior Approval	Prior Approval Required
Humatrope	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer